RAIN Rain Oncology Inc.
-
Rain Oncology Inc. Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Rain Oncology Inc. (RAIN) reported a loss of $0.40 per share on revenue of $0.00 million for the . .
Rain Oncology Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit.
Reported Earnings
($0.40)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—